Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of $58.30 billion as of September 30, 2025. Its market cap has decreased by -54.58% in one year.

• Market Cap: 58.30B
• Enterprise Value: 43.48B
• 1-Year Change: -54.58%
• Ranking: #262
• Category: Large-Cap
• Stock Price: $562.27

Market Cap Chart

Since December 1, 1998, Regeneron Pharmaceuticals's market cap has increased from $252.00M to $58.30B, an increase of 23,035.05%. That is a compound annual growth rate of 22.48%.

Market Cap History

Date	Market Cap	% Change
Sep 29, 2025	59.43B	-24.07%
Dec 31, 2024	78.28B	-18.19%
Dec 29, 2023	95.69B	21.78%
Dec 30, 2022	78.57B	15.69%
Dec 31, 2021	67.92B	31.74%
Dec 31, 2020	51.55B	25.04%
Dec 31, 2019	41.23B	1.98%
Dec 31, 2018	40.43B	0.08%
Dec 29, 2017	40.39B	4.33%
Dec 30, 2016	38.72B	-31.47%
Dec 31, 2015	56.49B	35.45%
Dec 31, 2014	41.71B	52.42%
Dec 31, 2013	27.36B	65.66%
Dec 31, 2012	16.52B	221.91%
Dec 30, 2011	5.13B	89.94%
Dec 31, 2010	2.70B	38.80%
Dec 31, 2009	1.95B	33.11%
Dec 31, 2008	1.46B	-8.46%
Dec 31, 2007	1.60B	38.55%
Dec 29, 2006	1.15B	29.12%
Dec 30, 2005	893.00M	73.94%
Dec 31, 2004	513.40M	-36.89%
Dec 31, 2003	813.50M	-0.20%
Dec 31, 2002	815.10M	-33.81%
Dec 31, 2001	1.23B	-5.01%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	684.97B
Johnson & Johnson	446.55B
AbbVie	409.03B
UnitedHealth Group	312.73B
Novartis AG	240.62B
Novo Nordisk	240.58B
Abbott Laboratories	233.12B
AstraZeneca	233.08B